| | 2370013-12-8 Basic information More.. |
| Product Name: | Sunvozertinib | | Synonyms: | 2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3R)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-;Sunvozertinib;(R)-N-(5-((4-((5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)phenyl)amino)pyrimidin-2-yl)amino)-2-(3-(dimethylamino)pyrrolidin-1-yl)-4-methoxyphenyl)acrylamide;Sunvozertinib, 10 mM in DMSO;N-{5-({4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl}amino)-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl}prop-2-enamide | | CAS: | 2370013-12-8 | | MF: | C29H35ClFN7O3 | | MW: | 584.08 | | EINECS: | | | Mol File: | 2370013-12-8.mol |  |
Sunvozertinib manufacturers
- Sunvozertinib
-
- US $399.00-398.00 / g
- 2022-12-29
- CAS:2370013-12-8
- Min. Order: 1g
- Purity: 99.99%HPLC.USP42——Powder、Oil、Pills、Capsules、Tablets，Customized packaging
- Supply Ability: 1kg
|
|
2370013-12-8
Recommend Suppliers |
|